Oral cytarabine ocfosfate in acute myeloid leukemia and non-Hodgkin's lymphoma--phase I/II studies and pharmacokinetics.

MLA

Braess, J., et al. “Oral Cytarabine Ocfosfate in Acute Myeloid Leukemia and Non-Hodgkin’s Lymphoma--Phase I/II Studies and Pharmacokinetics.” Leukemia, vol. 12, no. 10, Oct. 1998, pp. 1618–26. EBSCOhost, https://doi.org/10.1038/sj.leu.2401152.

APA

Braess, J., Freund, M., Hanauske, A., Heil, G., Kaufmann, C., Kern, W., Schüssler, M., Hiddemann, W., & Schleyer, E. (1998). Oral cytarabine ocfosfate in acute myeloid leukemia and non-Hodgkin’s lymphoma--phase I/II studies and pharmacokinetics. Leukemia, 12(10), 1618–1626. https://doi.org/10.1038/sj.leu.2401152

Chicago

Braess, J, M Freund, A Hanauske, G Heil, C Kaufmann, W Kern, M Schüssler, W Hiddemann, and E Schleyer. 1998. “Oral Cytarabine Ocfosfate in Acute Myeloid Leukemia and Non-Hodgkin’s Lymphoma--Phase I/II Studies and Pharmacokinetics.” Leukemia 12 (10): 1618–26. doi:10.1038/sj.leu.2401152.